Latest news
Novartis to highlight Rhapsido® data across multiple immune-mediated diseases at EAACI Congress 2026
Novartis IgAN data in The Lancet show clinically meaningful slowing of kidney function decline with Vanrafia® over 2.5 years
Novartis Cosentyx® PMR data in New England Journal of Medicine showed sustained remission vs placebo in twice as many patients
Manufacturing expansion in the United States
Novartis is expanding our manufacturing and R&D facilities in the US to scale innovation, help patients and create jobs.
Bringing breakthroughs to more patients
At Novartis, we don’t just discover life-changing medicines, we're part of a broader effort to help ensure medicines reach the people who need them most, wherever they live, because the true value of innovation lies in its ability to improve lives.
Annual reporting suite
Explore and download our Annual Report 2025, Report on Nonfinancial Matters 2025 and other reporting documents.